0001493152-20-009278.txt : 20200518 0001493152-20-009278.hdr.sgml : 20200518 20200518100050 ACCESSION NUMBER: 0001493152-20-009278 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200514 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEPORE PATRICK G CENTRAL INDEX KEY: 0001055404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 20888302 MAIL ADDRESS: STREET 1: 17-17 ROUTE 208 N CITY: FAIRLAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-443-1860 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 ownership.xml X0306 4 2020-05-14 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001055404 LEPORE PATRICK G C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER, NJ 07921 1 0 0 0 Common Stock, par value $0.0001 per share 2020-05-14 4 P 0 100000 0.7305 A 400000 D The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.7248 to $0.7399, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein. /s/ Keith A. Kucinski, attorney-in fact for Patrick G. LePore 2020-05-18